Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market in North America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Irritable Bowel Syndrome (IBS) and SIBO

5.2 Market Opportunities

5.2.1 Advantages of Breath Test

5.3 Future Trends

5.3.1 Development of Capsule Technology

5.4 Impact of Drivers and Restraints

6. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Regional Analysis

6.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Overview

6.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue 2019-2028 (US$ Thousand)

6.3 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast Analysis

7. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis – by Diagnosis

7.1 Breath Testing

7.1.1 Overview
7.1.2 Breath Testing: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)

7.2 Small Intestine Aspirate and Fluid Culture Test

7.2.1 Overview
7.2.2 Small Intestine Aspirate and Fluid Culture Test: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)

7.3 Blood Test

7.3.1 Overview
7.3.2 Blood Test: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)

8. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis – by Type

8.1 Hydrogen-predominant SIBO

8.1.1 Overview
8.1.2 Hydrogen-predominant SIBO: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

8.2 Methane-predominant SIBO

8.2.1 Overview
8.2.2 Methane-predominant SIBO: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

8.3 Recurrent SIBO

8.3.1 Overview
8.3.2 Recurrent SIBO : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

9. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – North America Analysis

9.1 North America

9.1.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
9.1.1.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast Analysis – by Country
9.1.1.1 US: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

9.1.1.1.1 US: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Diagnosis
9.1.1.1.2 US: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Type

9.1.1.2 Canada: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

9.1.1.2.1 Canada: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Diagnosis
9.1.1.2.2 Canada: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Type

9.1.1.3 Mexico : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

9.1.1.3.1 Mexico : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Diagnosis
9.1.1.3.2 Mexico : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Type

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Aerodiagnostics, LLC.

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Commonwealth Diagnostics International

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 DirectLabs, LLC.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Genova Diagnostics

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Health Associates Medical Group

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Metabolic Solutions, Inc.

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Pivotal Diagnostics

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 SIBO Diagnostics

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 SIBOTest

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Vibrant Wellness

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights